To include your compound in the COVID-19 Resource Center, submit it here.

Qiagen to acquire Ipsogen

Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) said it plans to acquire blood cancer diagnostic company Ipsogen S.A. (Euronext:ALIPS) for EUR

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE